Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H21N8O8PS4 |
Molecular Weight | 684.685 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SCC(SC3=NC(=CS3)C4=CC=[N+](C)C=C4)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C5=NSC(NP(O)([O-])=O)=N5)C(O)=O
InChI
InChIKey=ZCCUWMICIWSJIX-NQJJCJBVSA-N
InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13-/t14-,19-/m1/s1
Molecular Formula | C22H21N8O8PS4 |
Molecular Weight | 684.685 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:58:52 UTC 2023
by
admin
on
Fri Dec 15 15:58:52 UTC 2023
|
Record UNII |
7P6FQA5D21
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
J01DI02
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
||
|
NCI_THESAURUS |
C357
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZINFORO (AUTHORIZED PNEUMONIA, COMMONLY AQUIRED INFECTIONS)
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
||
|
WHO-VATC |
QJ01DI02
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000124156
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
CHEMBL501122
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
4169
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
7P6FQA5D21
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
DB06590
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
C81034
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
229016-73-3
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
9852981
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
DTXSID60177444
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
SUB31648
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
70714
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
7P6FQA5D21
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
1040004
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | RxNorm | ||
|
CEFTAROLINE FOSAMIL
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
70718
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
SS-47
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | |||
|
m3217
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY | Merck Index | ||
|
8827
Created by
admin on Fri Dec 15 15:58:52 UTC 2023 , Edited by admin on Fri Dec 15 15:58:52 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
URINE
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
EXCRETED UNCHANGED |
Approximately 64.3% of the dose was recovered in urine as unchanged ceftaroline in healthy young adult males (n=6) following single 1-hour IV infusion of [14C] ceftaroline fosamil 600 mg.
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|